Showing results (11-20 of 622) with videos related to
Sort By:
Pageof 63
Nuklearmedizin. Nuclear Medicine|April 6, 2021
[Impact of COVID-19 on Nuclear Medicine Procedures in Germany 2020 - Results of a National Survey]Lutz S Freudenberg, Markus Essler, Ken HerrmannNuklearmedizin. Nuclear Medicine|April 29, 2020
Impact of COVID-19 on Nuclear Medicine in Germany, Austria and Switzerland: An International Survey in April 2020Lutz S Freudenberg, Ulf Dittmer, Ken HerrmannInternational Journal of Molecular Sciences|February 15, 2022
Chaperone Therapy in Fabry DiseaseFrank Weidemann, Ana Jovanovic, Ken Herrmann, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions-Part 1Catello Somma, Richard Zimmermann, Germo Gericke, et al.Deutsches Arzteblatt International|March 29, 2018
CUP Syndrome-Metastatic Malignancy with Unknown Primary TumorGregor Zaun, Martin Schuler, Ken Herrmann, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2015
Value of functional imaging by PET in esophageal cancerThomas Schmidt, Florian Lordick, Ken Herrmann, et al.Therapeutics and Clinical Risk Management|July 2, 2020
Diagnosis and Screening of Patients with Fabry DiseaseIrfan Vardarli, Christoph Rischpler, Ken Herrmann, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions-Part 2Catello Somma, Richard Zimmermann, Germo Gericke, et al.Methods in Molecular Biology (Clifton, N.J.)|February 19, 2011
PET and PET-CT in esophageal and gastric cancerHinrich A Wieder, Bernd J Krause, Ken HerrmannJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2017
Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular StrategiesLisa Bodei, Valentina Ambrosini, Ken Herrmann, et al.Pageof 63